(Q33464907)

27 July 2017

title

Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial (English)

1 reference

27 July 2017

0 references

0 references

1 reference

Nermin Salkic

2

0 references

Goran Hauser

object named as

Goran Hauser

1

0 references

Davor Stimac

object named as

Davor Stimac

5

0 references

author name string

Karina Vukelic

3

1 reference

27 July 2017

Alenka JajacKnez

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

27 July 2017

1 reference

27 July 2017

volume

94

1 reference

27 July 2017

issue

17

1 reference

27 July 2017

page(s)

e685

1 reference

A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Clinical application of probiotics in the treatment of Helicobacter pylori infection--a brief review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Review article: Probiotics in gastrointestinal and liver diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Role of probiotics in patients with Helicobacter pylori infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Random allocation software for parallel group randomized trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Protection from gastrointestinal diseases with the use of probiotics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Probiotics for Helicobacter pylori eradication therapy: not ready for prime time.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Lactobacillus rhamnosus GG supplementation to reduce side-effects of anti-Helicobacter pylori treatment

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

The use of probiotics in Helicobacter pylori eradication therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4603068

[Croatian guidelines for diagnostics and treatments of Helicobacter pylori infection]

31 October 2018

1 reference

12 December 2020

Oral Bacterial Therapy Reduces the Duration of Symptoms and of Viral Excretion in Children with Mild Diarrhea

1 reference

12 December 2020

Oral bacteriotherapy for viral gastroenteritis

1 reference

12 December 2020

Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain

1 reference

12 December 2020

Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects

1 reference

12 December 2020

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

12 December 2020

Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease

1 reference

12 December 2020

Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model

1 reference

12 December 2020

Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial

1 reference

12 December 2020

Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy

1 reference

12 December 2020

Epidemiology and diagnosis of Helicobacter pylori infection

1 reference

12 December 2020

10.1097/MD.0000000000000685

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference